Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer

BACKGROUND: Little is known about prognosis of metastatic patients after receiving a first-line treatment and failure. Our group already showed in pre-treated patients enrolled in phase I clinical trials that a performance status (PS) > 2 and an LDH > 600 UI/L were independent prognostic facto...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Belbaraka, Rhizlane, Trédan, Olivier, Ray-Coquard, Isabelle, Chvetzoff, Giselle, Bajard, Agathe, Pérol, David, Ismaili, Nabil, Ismaili, Mohammed, Errihani, Hassan, Bachelot, Thomas, Rebattu, Paul
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2904794/
https://ncbi.nlm.nih.gov/pubmed/20537187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-3-164
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky